Catalyst Pharmaceuticals (CPRX) Inventory Average (2019 - 2026)

Catalyst Pharmaceuticals (CPRX) has 8 years of Inventory Average data on file, last reported at $36.0 million in Q1 2026.

• Quarterly Inventory Average rose 83.36% year-over-year to $36.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.0 million (up 83.36% YoY) and the FY2025 annual result came in at $28.4 million, up 61.17% from the prior year.
• Inventory Average climbed to $36.0 million in Q1 2026, from $32.6 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $36.0 million in Q1 2026 to a low of $7.0 million in Q4 2022.
• A 5-year average of $16.3 million and a median of $17.8 million in 2024 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2022 — Inventory Average declined 5.96% — and 2024, when it soared 107.77%.
• Tracing CPRX's Inventory Average over 5 years: stood at $7.0 million in 2022, then jumped by 77.08% to $12.3 million in 2023, then soared by 60.29% to $19.8 million in 2024, then soared by 64.81% to $32.6 million in 2025, then rose by 10.59% to $36.0 million in 2026.
• The last three Inventory Average figures came in at $36.0 million (Q1 2026), $32.6 million (Q4 2025), and $23.3 million (Q3 2025), per Business Quant data.